These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 35498431)

  • 1. Decoding the Therapeutic Implications of the ERα Stability and Subcellular Distribution in Breast Cancer.
    Tecalco-Cruz AC; Macías-Silva M; Ramírez-Jarquín JO; Ramírez-Jarquín UN
    Front Endocrinol (Lausanne); 2022; 13():867448. PubMed ID: 35498431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleo-cytoplasmic transport of estrogen receptor alpha in breast cancer cells.
    Tecalco-Cruz AC; Pérez-Alvarado IA; Ramírez-Jarquín JO; Rocha-Zavaleta L
    Cell Signal; 2017 Jun; 34():121-132. PubMed ID: 28341599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells.
    Hao L; Rizzo P; Osipo C; Pannuti A; Wyatt D; Cheung LW; Sonenshein G; Osborne BA; Miele L
    Oncogene; 2010 Jan; 29(2):201-13. PubMed ID: 19838210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor α revised: Expression, structure, function, and stability.
    Habara M; Shimada M
    Bioessays; 2022 Dec; 44(12):e2200148. PubMed ID: 36192154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen Receptor Alpha and its Ubiquitination in Breast Cancer Cells.
    Tecalco-Cruz AC; Ramírez-Jarquín JO; Cruz-Ramos E
    Curr Drug Targets; 2019; 20(6):690-704. PubMed ID: 30324876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance.
    Millour J; Constantinidou D; Stavropoulou AV; Wilson MS; Myatt SS; Kwok JM; Sivanandan K; Coombes RC; Medema RH; Hartman J; Lykkesfeldt AE; Lam EW
    Oncogene; 2010 May; 29(20):2983-95. PubMed ID: 20208560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation.
    Zhu J; Zhao C; Kharman-Biz A; Zhuang T; Jonsson P; Liang N; Williams C; Lin CY; Qiao Y; Zendehdel K; Strömblad S; Treuter E; Dahlman-Wright K
    Oncogene; 2014 Aug; 33(34):4340-51. PubMed ID: 24441041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock factor 1 (HSF1) cooperates with estrogen receptor α (ERα) in the regulation of estrogen action in breast cancer cells.
    Vydra N; Janus P; Kus P; Stokowy T; Mrowiec K; Toma-Jonik A; Krzywon A; Cortez AJ; Wojtas B; Gielniewski B; Jaksik R; Kimmel M; Widlak W
    Elife; 2021 Nov; 10():. PubMed ID: 34783649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Williams syndrome transcription factor (WSTF) acts as an activator of estrogen receptor signaling in breast cancer cells and the effect can be abrogated by 1α,25-dihydroxyvitamin D
    Lundqvist J; Kirkegaard T; Laenkholm AV; Duun-Henriksen AK; Bak M; Feldman D; Lykkesfeldt AE
    J Steroid Biochem Mol Biol; 2018 Mar; 177():171-178. PubMed ID: 28610873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
    Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
    Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancer.
    Tecalco-Cruz AC; Ramírez-Jarquín JO
    World J Clin Oncol; 2018 Aug; 9(4):60-70. PubMed ID: 30148069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ctr9, a key subunit of PAFc, affects global estrogen signaling and drives ERα-positive breast tumorigenesis.
    Zeng H; Xu W
    Genes Dev; 2015 Oct; 29(20):2153-67. PubMed ID: 26494790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
    Arendt LM; Rugowski DE; Grafwallner-Huseth TA; Garcia-Barchino MJ; Rui H; Schuler LA
    Breast Cancer Res; 2011 Jan; 13(1):R11. PubMed ID: 21276249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.
    Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J
    Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different epigenetic mechanisms of ERα implicated in the fate of fulvestrant-resistant breast cancer.
    Tsuboi K; Kaneko Y; Nagatomo T; Fujii R; Hanamura T; Gohno T; Yamaguchi Y; Niwa T; Hayashi SI
    J Steroid Biochem Mol Biol; 2017 Mar; 167():115-125. PubMed ID: 27888136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM11 promotes breast cancer cell proliferation by stabilizing estrogen receptor α.
    Tang J; Luo Y; Tian Z; Liao X; Cui Q; Yang Q; Wu G
    Neoplasia; 2020 Sep; 22(9):343-351. PubMed ID: 32599554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach.
    Tozlu S; Girault I; Vacher S; Vendrell J; Andrieu C; Spyratos F; Cohen P; Lidereau R; Bieche I
    Endocr Relat Cancer; 2006 Dec; 13(4):1109-20. PubMed ID: 17158757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KLF17 attenuates estrogen receptor α-mediated signaling by impeding ERα function on chromatin and determines response to endocrine therapy.
    Ali A; Ielciu I; Alkreathy HM; Khan AA
    Biochim Biophys Acta; 2016 Jul; 1859(7):883-95. PubMed ID: 27107895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphiregulin Is a Critical Downstream Effector of Estrogen Signaling in ERα-Positive Breast Cancer.
    Peterson EA; Jenkins EC; Lofgren KA; Chandiramani N; Liu H; Aranda E; Barnett M; Kenny PA
    Cancer Res; 2015 Nov; 75(22):4830-8. PubMed ID: 26527289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Non-Coding RNA H19 Acts as an Estrogen Receptor Modulator that is Required for Endocrine Therapy Resistance in ER+ Breast Cancer Cells.
    Basak P; Chatterjee S; Bhat V; Su A; Jin H; Lee-Wing V; Liu Q; Hu P; Murphy LC; Raouf A
    Cell Physiol Biochem; 2018; 51(4):1518-1532. PubMed ID: 30497079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.